Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
New strategies for prevention and treatment of type 2 diabetes (T2D) require improved insight into disease etiology. We analyzed 386,731 common single-nucleotide polymorphisms (SNPs) in 1464 patients with T2D and 1467 matched controls, each characterized for measures of glucose metabolism, lipids, obesity, and blood pressure. With collaborators (FUSION and WTCCC/UKT2D), we identified and confirmed three loci associated with T2D—in a noncoding region near CDKN2A and CDKN2B , in an intron of IGF2BP2 , and an intron of CDKAL1 —and replicated associations near HHEX and in SLC30A8 found by a recent whole-genome association study. We identified and confirmed association of a SNP in an intron of glucokinase regulatory protein (GCKR) with serum triglycerides. The discovery of associated variants in unsuspected genes and outside coding regions illustrates the ability of genome-wide association studies to provide potentially important clues to the pathogenesis of common diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This idea, combined with the development of efficient methods for surveying large numbers of SNPs, has led to the many recent genome-wide association (GWA) studies that have detected SNPs that are significantly associated with breast cancer79,80, colorectal cancer81,82, type 2 diabetes83–86 and heart disease87,88, among other diseases.”
From Linkage disequilibrium--understanding the evolutionary past and mapping the medical future. (2008) · cites this paper as [83]
In the citing paper
“These studies identified single-nucleotide polymorphisms (SNPs) in the second intron of the IGF2BP2 gene, particularly rs4402960 and rs1470579, as being significantly associated with an increased risk of T2D across various populations.”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [70]
In the citing paper
“The association between IMP2 and T2D was first identified through genome-wide association studies (GWAS) in 2007, with three independent research groups demonstrating a strong link between genetic variants in the IGF2BP2 gene and T2D risk [69,70,71].”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [70]
In the citing paper
“The complexity of the genetic factors that contribute to type 2 diabetes risk is substantial (272,273).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [272]
In the citing paper
“Recent genome-wide association studies have identified .30genetic factors that increase the risk for type 2 diabetes (272,273).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [272]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Self-citationA genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Self-citationVariant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Efficiency and power in genetic association studies
de Bakker, P. I. W., Yelensky, R., Pe'er, I., Gabriel, S. B., Daly, M. J., & Altshuler, D. (2005) · Nature Genetics · doi:10.1038/ng1669 · Cited by 1,688
Self-citationDeeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Research works printed but not linked: 3
- R. A. Fisher, Trans. R. Soc. Edinb.52, 399 (1918).
- The Wellcome Trust Case Control Consortium Nature in press.
- F. C. Nielsen, J. Nielsen, J. Christiansen, Scand. J. Clin. Lab. Invest. Suppl.234, 93 (2001).
Cited by
Items 501–600 of 1,017
Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice
da Silva Xavier, G., Mondragon, A., Sun, G., Chen, L., McGinty, J. A., French, P. M., & Rutter, G. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2600-7 · Cited by 109
“Genome-wide association studies (GWAS) for type 2 diabetes, first reported in 2007 [4–8], have now revealed nearly 50 loci associated with the disease [9, 10].”
BackgroundGamboa-Meléndez, M. A., Huerta‐Chagoya, A., Moreno-Macías, H., Vázquez-Cárdenas, P., Ordóñez-Sánchez, M. L., Rodríguez-Guillén, R., Riba, L., Rodríguez-Torres, M., Guerra-García, M. T., Guillén-Pineda, L. E., et al. (2012) · Diabetes · doi:10.2337/db11-0550 · Cited by 120
Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells
Xiong, X.-D., Ren, X., Cai, M., Yang, J. W., Liu, X., & Yang, J. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.001 · Cited by 120
Gene–Environment Interactions and Susceptibility to Metabolic Syndrome and Other Chronic Diseases
Ordovas, J. M., & Shen, J. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080232 · Cited by 109
Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
Müssig, K., Staiger, H., Machicao, F., Kirchhoff, K., Guthoff, M., Schäfer, S. A., Kantartzis, K., Silbernagel, G., Stefan, N., Holst, J. J., et al. (2009) · Diabetes · doi:10.2337/db08-1589 · Cited by 109
The success of the genome-wide association approach: a brief story of a long struggle
Seng, K. C., & Seng, C. K. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.12 · Cited by 121
Insulin Stimulates Primary β-Cell Proliferation via Raf-1 Kinase
Beith, J. L., Alejandro, E. U., & Johnson, J. D. (2008) · Endocrinology · doi:10.1210/en.2007-1557 · Cited by 109
The physiological role of drug transporters
Liang, Y., Li, S., & Chen, L. (2015) · Protein & Cell · doi:10.1007/s13238-015-0148-2 · Cited by 130
Tissue-specific alternative splicing of TCF7L2
Prokunina‐Olsson, L., Welch, C., Hansson, O., Adhikari, N., Scott, L. J., Usher, N., Tong, M., Sprau, A. G., Swift, A. J., Bonnycastle, L. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp321 · Cited by 112
“We identified several TSS: (1) TSS1, located at 2536 bp from the first translation start site and corresponding to RefSeq sequence (NM_030756); (2) TSS2, located at position þ83 bp within exon 1; (3) a cluster collectively referred as TSS3 located in the first intron of the gene (þ200, þ239, þ302, þ338 bp, Fig.”
BackgroundSelf-citationRönn, T., Wen, J., Yang, Z., Lü, B., Du, Y., Groop, L., Hu, R., & Ling, C. (2009) · Diabetologia · doi:10.1007/s00125-009-1297-8 · Cited by 112
“A recent genome-wide association study (GWAS) has identified a polymorphism (rs10830963) in MTNR1B, which encodes melatonin receptor 1B, which is associated with glucose-stimulated insulin secretion [1].”
BackgroundSelf-citationRequired sample size and nonreplicability thresholds for heterogeneous genetic associations
Moonesinghe, R., Khoury, M. J., Liu, T., & Ioannidis, J. P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705554105 · Cited by 108
Progress in the genetics of common obesity and type 2 diabetes
Vimaleswaran, K. S., & Loos, R. J. F. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001389 · Cited by 107
Iwata, M., Maeda, S., Kamura, Y., Takano, A., Kato, H., Murakami, S., Higuchi, K., Takahashi, A., Fujita, H., Hara, K., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2006 · Cited by 107
A decade in psychiatric GWAS research
Horwitz, T., Lam, K., Chen, Y., Xia, Y., & Liu, C. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0055-z · Cited by 105
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 138
Advanced research on risk factors of type 2 diabetes
Bi, Y., Wang, T., Xu, M., Xu, Y., Li, M., Lu, J., Zhu, X., & Ning, G. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2352 · Cited by 106
Ruchat, S.-M., Elks, C. E., Loos, R. J. F., Vohl, M., Weisnagel, S. J., Rankinen, T., Bouchard, C., & Përusse, L. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0080-5 · Cited by 116
“Recent GWAS have identified novel T2DM susceptibility loci within the genes encoding CDKAL1, CDKN2B, HHEX/IDE, IGF2BP2, SLC30A8 and TCF2 and have confirmed those in PPARG, KCNJ11, TCF7L2 and WFS1 [2–7, 9].”
BackgroundMethodSteneberg, P., Bernardo, L., Edfalk, S., Lundberg, L., Backlund, F., Östenson, C.-G., & Edlund, H. (2013) · Diabetes · doi:10.2337/db12-1045 · Cited by 106
Hromatka, B. S., Tung, J. Y., Kiefer, A. K., Do, C. B., Hinds, D. A., & Eriksson, N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv028 · Cited by 105
Koeck, T., Olsson, A. H., Nitert, M. D., Sharoyko, V. V., Ladenvall, C., Kotova, O., Reiling, E., Rönn, T., Parikh, H., Taneera, J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.007 · Cited by 105
Self-citationStatistical analysis for genome-wide association study
Ping, Z., Zhao, Y., Cheng, Q., Li-wei, Z., Zhang, R., Jianwei, G., Jin, L., Liya, L., & Feng, C. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20140007 · Cited by 137
“The issues regarding data quality control, population structure, association analysis, multiple comparison and visual presentation of GWAS results are discussed; other advanced topics including the issue of missing heritability, meta-analysis, setbased association analysis, copy number variation…”
BackgroundGIANT Consortium, Wojciechowski, P., Lipowska, A., Rys, P., Ewens, K. G., Franks, S., Tan, S., Lerchbaum, E., Vcelak, J., Attaoua, R., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2638-6 · Cited by 105
“This SNP has also been associated with higher odds of type 2 diabetes, although this effect can be entirely explained by its impact on BMI in affected and unaffected individuals [3, 8–11].”
BackgroundLipidomics is providing new insight into the metabolic syndrome and its sequelae
Meikle, P. J., & Christopher, M. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283453dbe · Cited by 121
Holdt, L. M., & Teupser, D. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00145 · Cited by 108
Gonzalez, R., Jennings, L. L., Knuth, M., Orth, A. P., Klock, H. E., Ou, W., Feuerhelm, J., Hull, M. V., Koesema, E., Wang, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914019107 · Cited by 104
Self-citationZhai, G., Teumer, A., Stolk, L., Perry, J. R. B., Vandenput, L., Coviello, A. D., Koster, A., Bell, J. T., Bhasin, S., Eriksson, J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002025 · Cited by 105
Mitchell, R. K., Mondragon, A., Chen, L., McGinty, J., French, P. M. W., Ferrer, J. P., Thorens, B., Hodson, D. J., Rutter, G. A., & Xavier, G. D. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu553 · Cited by 112
Little, J., Higgins, J. P. T., Ioannidis, J. P. A., Moher, D., Gagnon, F., von Elm, E. B., Khoury, M. J., Cohen, B. J., Smith, G. D., Grimshaw, J., et al. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.12.004 · Cited by 106
Interrogating Type 2 Diabetes Genome-Wide Association Data Using a Biological Pathway-Based Approach
Perry, J. R. B., McCarthy, M. I., Hattersley, A. T., Zeggini, E., the Wellcome Trust Case Control Consortium, Weedon, M. N., & Frayling, T. M. (2009) · Diabetes · doi:10.2337/db08-1378 · Cited by 104
Dai, N., Ji, F., Wright, J., Minichiello, L., Sadreyev, R., & Avruch, J. (2017) · eLife · doi:10.7554/elife.27155 · Cited by 103
“Funder Grant reference number Author National Institute of Diabetes and Digestive and Kidney Diseases R37 DK17776 Joseph Avruch National Institute of Diabetes and Digestive and Kidney Diseases P30 DK057521 Joseph Avruch National Institute of Diabetes and Digestive and Kidney Diseases P30 DK040561 Ruslan Sadreyev The f…”
BackgroundInfluentialCho, S., Kim, K., Kim, Y. J., Lee, J., Cho, Y. S., Lee, J., Han, B., Kim, H., Ott, J., & Park, T. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2010.00597.x · Cited by 118
“In recent years, GWA studies have led to many discoveries of genetic variants affecting com§ mon complex traits, including height, blood pressure and diabetes (Saxena et al., 2007; Sladek et al., 2007; Li et al., 2008; Wallace et al., 2008; Weedon et al., 2008; Thorleifsson et al., 2009).”
BackgroundHurst, C. D., Tomlinson, D. C., Williams, S. V., Platt, F. M., & Knowles, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210934 · Cited by 117
Hirschhorn, J. N., & Gajdos, Z. K. Z. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.091708.162036 · Cited by 119
Self-citationExtension of Type 2 Diabetes Genome-Wide Association Scan Results in the Diabetes Prevention Program
Moore, A. F., Jablonski, K. A., McAteer, J. B., Saxena, R., Pollin, T. I., Franks, P. W., Hanson, R. L., Shuldiner, A. R., Knowler, W. C., Altshuler, D., et al. (2008) · Diabetes · doi:10.2337/db08-0284 · Cited by 103
Self-citationDiabetes in China: epidemiology, pathophysiology and multi-omics
Jia, W., Chan, J. C. N., Wong, T. Y., & Fisher, E. B. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01190-w · Cited by 116
Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population
Reddy, M. P. L., Wang, H., Liu, S., Bode, B. W., Reed, J. H. C., Steed, R. D., Anderson, S. W., Steed, L., Hopkins, D., & She, J.-X. (2011) · Genes and Immunity · doi:10.1038/gene.2010.70 · Cited by 110
A Variant in the KCNQ1 Gene Predicts Future Type 2 Diabetes and Mediates Impaired Insulin Secretion
Jonsson, A., Isomaa, B., Tuomi, T., Taneera, J., Salehi, A., Nilsson, P., Groop, L., & Lyssenko, V. (2009) · Diabetes · doi:10.2337/db09-0246 · Cited by 102
Self-citationHormonal and Metabolite Regulation of Hepatic Glucokinase
Agius, L. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-051145 · Cited by 101
Problems with Genome-Wide Association Studies
Shriner, D., Vaughan, L. K., Padilla, M. A., & Tiwari, H. K. (2007) · Science · doi:10.1126/science.316.5833.1840c · Cited by 106
Genetics of Cardiovascular Diseases: From Single Mutations to the Whole Genome
Cambien, F., & Tiret, L. (2007) · Circulation · doi:10.1161/circulationaha.106.661751 · Cited by 120
Paré, G., Chasman, D. I., Parker, A. N., Nathan, D. M., Miletich, J. P., Zee, R. Y., & Ridker, P. M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000312 · Cited by 100
“Since several SNPs have been unequivocally associated with type 2 diabetes, we tested whether these ‘‘candidate’’ SNPs [1,4,31,32] were associated with glycated hemoglobin as well (Table 5).”
BackgroundStark, K. J., Reinhard, W., Neureuther, K., Wiedmann, S., Sedláček, K., Baessler, A., Fischer, M., Weber, S., Kaess, B. M., Erdmann, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001948 · Cited by 97
Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer?
Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002145 · Cited by 105
Hegele, R. A., Ban, M. R., Hsueh, N., Kennedy, B. A., Cao, H., Zou, G. Y., Anand, S., Yusuf, S., Huff, M. W., & Wang, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp361 · Cited by 100
Zhong, H., & Prentice, R. L. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20437 · Cited by 94
Genetics of polycystic ovary syndrome
Mykhalchenko, K., Lizneva, D., Trofimova, T., Walker, W., Suturina, L., Diamond, M. P., & Azziz, R. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1340833 · Cited by 98
Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease
Johnson, S. C. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_3 · Cited by 110
Jonsson, A., Ladenvall, C., Ahluwalia, T. S., Kravic, J., Krus, U., Taneera, J., Isomaa, B., Tuomi, T., Renström, E., Groop, L., et al. (2013) · Diabetes · doi:10.2337/db12-1627 · Cited by 99
“Insulin sensitivity index (ISI) was calculated as 10,000/√(fasting P-glucose×fasting Pinsulin×meanOGTTglucose×meanOGTTinsulin) [4].”
BackgroundMethodInfluentialSelf-citationTotal Zinc Intake May Modify the Glucose-Raising Effect of a Zinc Transporter (SLC30A8) Variant
Kanoni, S., Nettleton, J. A., Hivert, M.-F., Ye, Z., van Rooij, F. J. A., Shungin, D., Sonestedt, E., Ngwa, J. S., Wojczynski, M. K., Lemaitre, R. N., et al. (2011) · Diabetes · doi:10.2337/db11-0176 · Cited by 99
Self-citationShan, Z., Bao, W., Zhang, Y., Rong, Y., Wang, X., Jin, Y., Song, Y., Yao, P., Sun, C., Hu, F. B., et al. (2014) · Diabetes · doi:10.2337/db13-0606 · Cited by 99
Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms
van der Harst, P., Bakker, S. J. L., de Boer, R. A., Wolffenbuttel, B. H. R., Johnson, T., Caulfield, M. J., & Navis, G. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp489 · Cited by 99
Short Telomeres Compromise β-Cell Signaling and Survival
Guo, N., Parry, E. M., Li, L.-S., Kembou, F., Lauder, N., Hussain, M. A., Berggren, P.-O., & Armanios, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017858 · Cited by 100
Goustin, A. S., & Abou‐Samra, A. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.003 · Cited by 104
Diabetes and cancer risk: A Mendelian randomization study
Goto, A., Yamaji, T., Sawada, N., Momozawa, Y., Kamatani, Y., Kubo, M., Shimazu, T., Inoue, M., Noda, M., Tsugane, S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32310 · Cited by 115
Genome-Wide Association Studies in an Isolated Founder Population from the Pacific Island of Kosrae
Lowe, J. K., Maller, J. B., Pe'er, I., Neale, B. M., Salit, J., Kenny, E. E., Shea, J. L., Burkhardt, R., Smith, J. G., Ji, W., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000365 · Cited by 98
“Meta-analysis of these data with publicly available results from the Diabetes Genetics Initiative [33] produces a combined p-value of 2.10 6 10 2 6 , with 7 other neighboring SNPs producing combined p-values of 2.53 6 10 2 6 to 5.73 6 10 2 6 .”
InfluentialSelf-citationNakano, M., Ikeda, Y., Tokuda, Y., Fuwa, M., Omi, N., Ueno, M., Imai, K., Adachi, H., Kageyama, M., Mori, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033389 · Cited by 100
Hanson, R. L., Bogardus, C., Duggan, D., Kobes, S., Knowlton, M., Infante, A. M., Marovich, L., Benitez, D., Baier, L. J., & Knowler, W. C. (2007) · Diabetes · doi:10.2337/db07-0462 · Cited by 98
“The “sentinel” SNP is the one with the strongest association with diabetes across multiple genome-wide association studies (47-50).”
BackgroundKokil, G. R., Veedu, R. N., Ramm, G. A., Prins, J. B., & Parekh, H. S. (2015) · Chemical Reviews · doi:10.1021/cr5002832 · Cited by 108
Precision medicine in diabetes prevention, classification and management
Xie, F., Chan, J. C., & Ma, R. C. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12830 · Cited by 97
Gene Set Enrichment in eQTL Data Identifies Novel Annotations and Pathway Regulators
Wu, C., Delano, D. L., Mitro, N., Su, S. V., Janes, J. O., McClurg, P., Batalov, S., Welch, G. L., Zhang, J., Orth, A. P., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000070 · Cited by 108
Power to Detect Risk Alleles Using Genome-Wide Tag SNP Panels
Eberle, M. A., Ng, P. C., Kuhn, K., Zhou, L., Peiffer, D. A., Galver, L., Viaud-Martinez, K. A., Lawley, C. T., Gunderson, K. L., Shen, R., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030170 · Cited by 97
Hertel, J. K., Johansson, S., Ræder, H., Midthjell, K., Lyssenko, V., Groop, L., Molven, A., & Njølstad, P. R. (2008) · Diabetologia · doi:10.1007/s00125-008-0982-3 · Cited by 100
“The DGI defined two loci, FLJ39370 and PKN2, as interesting for follow-up studies [3], whereas the WTCCC and FUSION studies showed conflicting results [4, 5].”
BackgroundResultInfluentialSelf-citationPleiotropic Effects of GIP on Islet Function Involve Osteopontin
Lyssenko, V., Eliasson, L., Kotova, O., Pilgaard, K., Wierup, N., Salehi, A., Wendt, A., Jonsson, A., De Marinis, Y. Z., Berglund, L. M., et al. (2011) · Diabetes · doi:10.2337/db10-1532 · Cited by 98
Self-citationCheng, C.-Y., Reich, D., Haiman, C. A., Tandon, A., Patterson, N., Elizabeth, S., Akylbekova, E. L., Brancati, F. L., Coresh, J., Boerwinkle, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032840 · Cited by 97
Self-citationPancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Ehses, J. A., Ellingsgaard, H., Böni-Schnetzler, M., & Donath, M. Y. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903025879 · Cited by 97
“The genetics of type 2 diabetes has received a wave of attention following the findings of recent genome wide association (GWA) studies (Saxena et al., 2007; Scott et al., 2007; Sladek et al., 2007; Steinthorsdottir et al., 2007; Zeggini et al., 2007).”
BackgroundPPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis
Sarhangi, N., Sharifi, F., Hashemian, L., Doabsari, M. H., Heshmatzad, K., Rahbaran, M., Jamaldini, S. H., Meybodi, H. R. A., & Hasanzad, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69363-7 · Cited by 113
Modelling the endocrine pancreas in health and disease
Bakhti, M., Böttcher, A., & Lickert, H. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0132-z · Cited by 126
Pharmacogenetics of Anti-Diabetes Drugs
DiStefano, J. K., & Watanabe, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3082610 · Cited by 107
“As of this writing, 38 loci underlying susceptibility to T2D have been identified, mostly in populations of northern European ancestry [206-217].”
BackgroundZhang, Y., Yang, L., Yuan-fu, G., Fan, Z., Cai, X., Liu, M., Guo, X., Gao, C., & Xia, Z. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.004 · Cited by 98
Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors
Lloyd, D. J., Jean, D. J. S., Kurzeja, R. J. M., Wahl, R. C., Michelsen, K., Cupples, R. L., Chen, M., Wu, J. W. Y., Sivits, G. N., Helmering, J., et al. (2013) · Nature · doi:10.1038/nature12724 · Cited by 95
Gene-Based Tests of Association
Huang, H., Chanda, P., Alonso, A., Bader, J. S., & Arking, D. E. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002177 · Cited by 95
The ENPP1 K121Q Polymorphism Is Associated With Type 2 Diabetes in European Populations
McAteer, J. B., Prudente, S., Bacci, S., Lyon, H. N., Hirschhorn, J. N., Trischitta, V., & Florez, J. C. (2007) · Diabetes · doi:10.2337/db07-1336 · Cited by 95
Self-citationA 100K Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study
Florez, J. C., Manning, A. K., Dupuis, J., McAteer, J., Irenze, K., Gianniny, L., Mirel, D. B., Fox, C. S., Cupples, L. A., & Meigs, J. B. (2007) · Diabetes · doi:10.2337/db07-0451 · Cited by 95
Self-citationGenetics of diabetes-associated microvascular complications
Lyssenko, V., & Vaag, A. A. (2023) · Diabetologia · doi:10.1007/s00125-023-05964-x · Cited by 113
Self-citationMyers, S., Nield, A., & Myers, M. A. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/173712 · Cited by 115
“Several genomewide association studies (GWASs) have implicated ZnT8 in T2DM in humans [8, 155–157].”
BackgroundHeid, I. M., Boes, E., Müller, M., Kollerits, B., Lamina, C., Coassin, S., Gieger, C., Döring, A., Klopp, N., Frikke-Schmidt, R., et al. (2008) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.776708 · Cited by 94
β-Cell deterioration during diabetes: what’s in the gun?
Robertson, R. P. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.05.004 · Cited by 93
Islet biology, the CDKN2A/B locus and type 2 diabetes risk
Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3967-7 · Cited by 103
Cropano, C. M., Santoro, N., Groop, L., Man, C. D., Cobelli, C., Galderisi, A., Kursawe, R., Pierpont, B. M., Goffredo, M., & Caprio, S. (2017) · Diabetes Care · doi:10.2337/dc17-0290 · Cited by 103
Self-citationWnt Signaling in Pancreatic Islets
Liu, Z., & Habener, J. F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_17 · Cited by 98
Ko, D. C., Shukla, K. P., Fong, C. T., Wasnick, M., Brittnacher, M., Wurfel, M. M., Holden, T. D., O’Keefe, G. E., Yserloo, B. V., Akey, J. M., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.07.012 · Cited by 94
Stančáková, A., Paananen, J., Soininen, P., Kangas, A. J., Bonnycastle, L. L., Morken, M. A., Collins, F. S., Jackson, A. U., Boehnke, M. L., Kuusisto, J., et al. (2011) · Diabetes · doi:10.2337/db10-1655 · Cited by 93
Palmer, C. N. A., Maglio, C., Pirazzi, C., Burza, M. A., Adiels, M., Burch, L., Donnelly, L. A., Colhoun, H., Doney, A. S., Dillon, J. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039362 · Cited by 96
Association study of 182 candidate genes in anorexia nervosa
Pinheiro, A. P., Bulik, C. M., Thornton, L. M., Sullivan, P. F., Root, T. L., Bloss, C. S., Berrettini, W. H., Schork, N. J., Kaye, W. H., Bergen, A. W., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31082 · Cited by 92
“…for T1DM, T2DM, Crohn’s disease, cardiovascular disease, prostate cancer, breast cancer, body mass index, nicotine addiction, and height [Bierut et al., 2007; Consortium, 2007; Frayling et al., 2007; Saxena et al., 2007; Scott et al., 2007; Berrettini et al., 2008; Thorgeirsson et al., 2008].”
BackgroundFoxM1 Is Up-Regulated by Obesity and Stimulates β-Cell Proliferation
Davis, D. B., Lavine, J. A., Suhonen, J. I., Krautkramer, K. A., Rabaglia, M. E., Sperger, J. M., Fernandez, L. A., Yandell, B. S., Keller, M. P., Wang, I.-M., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0082 · Cited by 91
Precision medicine in type 2 diabetes
Prasad, R. B., & Groop, L. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12859 · Cited by 91
Self-citationThe Genetic Architecture of Intracerebral Hemorrhage
Rost, N. S., Greenberg, S. M., & Rosand, J. M. (2008) · Stroke · doi:10.1161/strokeaha.107.501650 · Cited by 100
Genomics of type 2 diabetes mellitus: implications for the clinician
Stolerman, E. S., & Florez, J. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.129 · Cited by 99
Self-citationSobrin, L., Green, T. J., Sim, X., Jensen, R. A., Tai, E. S., Tay, W. T., Wang, J. J., Mitchell, P. L. R., Sandholm, N., Liu, Y., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7510 · Cited by 100
Self-citationTakeuchi, F., Katsuya, T., Chackrewarthy, S., Yamamoto, K., Fujioka, A., Serizawa, M., Fujisawa, T., Nakashima, E., Ohnaka, K., Ikegami, H., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1595-1 · Cited by 91
Berisha, S. Z., Serre, D., Schauer, P., Kashyap, S. R., & Smith, J. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016729 · Cited by 90
Palmer, N. D., Hester, J. M., An, S. S., Adeyemo, A., Rotimi, C. N., Langefeld, C. D., Freedman, B. I., Ng, M. C. Y., & Bowden, D. W. (2010) · Diabetes · doi:10.2337/db10-0134 · Cited by 92
The pathogenetic role of β-cell mitochondria in type 2 diabetes
Fex, M., Nicholas, L. M., Vishnu, N., Medina, A., Sharoyko, V. V., Nicholls, D. G., Spégel, P., & Mulder, H. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0367 · Cited by 102
Wang, Y., Nie, M., Li, W., Ping, F., Hu, Y., Ma, L., Gao, J., & Liu, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026953 · Cited by 90
Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
Brockmöller, J., & Tzvetkov, M. V. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0424-z · Cited by 116
An Overview of Population Genetic Data Simulation
Yuan, X., Miller, D. J., Zhang, J., Herrington, D. M., & Wang, Y. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0188 · Cited by 106
“Genome-wide association studies (GWAS) is an example of a commonly applied methodology in this field (Hirschhorn and Daly, 2005; Marchini et al., 2005; Saxena et al., 2007).”
MethodLin, Y., Li, P., Cai, L., Zhang, B., Tang, X., Zhang, X., Li, Y., Xian, Y., Yang, Y., Wang, L., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-97 · Cited by 90
Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway
Mu, Q., Wang, L., Yu, F., Gao, H., Lei, T., Li, P., Liu, P., Zheng, X., Hu, X., Chen, Y., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1019185 · Cited by 89
Schäfer, S., Müssig, K., Staiger, H., Machicao, F. E., Stefan, N., Gallwitz, B., Häring, H.-U., & Fritsche, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1344-5 · Cited by 92
“IGF2BP2 and CDKN2A/B, none of which was in the list of functional candidates [1–4].”
BackgroundSmidt, K., Jessen, N., Petersen, A. B., Larsen, A., Magnusson, N., Jeppesen, J. B., Stoltenberg, M., Culvenor, J. G., Tsatsanis, A., Brock, B., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005684 · Cited by 89
Metadata
- Authors
- Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., Hughes, T. E., Groop, L., Altshuler, D., Almgren, P., Florez, J. C., Meyer, J., Ardlie, K., Bengtsson Boström, K., Isomaa, B., Lettre, G., Lindblad, U., Lyon, H. N., Melander, O., Newton-Cheh, C., Nilsson, P., Orho-Melander, M., Råstam, L., Speliotes, E. K., Taskinen, M.-R., Tuomi, T., Guiducci, C., Berglund, A., Carlson, J., Gianniny, L., Hackett, R., Hall, L., Holmkvist, J., Laurila, E., Sjögren, M., Sterner, M., Surti, A., Svensson, M., Svensson, M., Tewhey, R., Blumenstiel, B., Parkin, M., DeFelice, M., Barry, R., Brodeur, W., Camarata, J., Chia, N., Fava, M., Gibbons, J., Handsaker, B., Healy, C., Nguyen, K., Gates, C., Sougnez, C., Gage, D., Nizzari, M., Gabriel, S. B., Chirn, G.-W., Ma, Q., Parikh, H., Richardson, D., Ricke, D., & Purcell, S.
- Affiliations
- Broad Institute (US)
- Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA 02142, USA.
- ORCID
- Saxena, Richa
- Voight, Benjamin F.
- Lyssenko, Valeriya
- Chen, Hong
- Kathiresan, Sekar
- Hirschhorn, Joel N.
- Daly, Mark J.
- Hughes, Thomas E.
- Groop, Leif
- Altshuler, David
- Almgren, Peter
- Ardlie, Kristin
- Lettre, Guillaume
- Lindblad, Ulf
- Melander, Olle
- Nilsson, Peter
- Speliotes, Elizabeth K.
- Taskinen, Marja-Riitta
- Hackett, Rachel
- Tewhey, Ryan
- DeFelice, Matthew
- Gibbons, John
- Healy, Claire
- Gabriel, Stacey B.
- Parikh, Hemang
- Ricke, Darrell
- Purcell, Shaun
- Venue
- Science
- Published
- 2007-06
- Volume
- 316
- Issue
- 5829
- Pages
- 1331-1336
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2048755332
- Cited by
- 2,843
- References
- 28
- Citations by year
- 2026: 14 · 2025: 35 · 2024: 47 · 2023: 54 · 2022: 66 · 2021: 87 · 2020: 63 · 2019: 76 · 2018: 95 · 2017: 88 · 2016: 116 · 2015: 142 · 2014: 152 · 2013: 155 · 2012: 203
- FWCI
- 216.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health (5k23hl083102-02)
- National Heart, Lung, and Blood Institute (K23-HL-083102)
- National Human Genome Research Institute (U01HG004171)
- National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK-65978-04, K23DK067288, F32DK079466, K23DK080145, K23DK065978)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, triglyceride levels, genetic loci, single nucleotide polymorphisms, CDKN2A/CDKN2B, IGF2BP2, CDKAL1, HHEX, SLC30A8, GCKR, non-coding variants, disease susceptibility, glucose metabolism, lipid metabolism
- MeSH terms
- Aged, Alleles, Blood Glucose, Chromosome Mapping, Chromosomes, Human, Pair 9, Diabetes Mellitus, Type 2, Female, Genetic Markers, Genotype, Haplotypes, Humans, Insulin Resistance, Introns, Male, Middle Aged, Triglycerides, Meta-Analysis as Topic, Genome, Human, Case-Control Studies, Insulin-Like Growth Factor Binding Proteins, Quantitative Trait, Heritable, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.